Final clinical results of a randomized phase II international trial of everolimus vs. sunitinib in patients with metastatic non-clear cell renal cell carcinoma (ASPEN)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Armstrong, AJ; Broderick, S; Eisen, T; Stadler, WM; Jones, RJ; Garcia, JA; Vaishampayan, UN; Picus, J; Hawkins, RE; Hainsworth, JD; Kollmannsberger, CK; Logan, TF; Puzanov, I; Pickering, LM; Ryan, CW; Protheroe, A; Lusk, CM; Oberg, S; Halabi, S; George, DJ

Published Date

  • May 20, 2015

Published In

Volume / Issue

  • 33 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Conference Location

  • Chicago, IL

Conference Start Date

  • May 29, 2015

Conference End Date

  • June 2, 2015